Sulfasalazine can be taken indefinitely. It is designed as a long-term medication for chronic conditions like rheumatoid arthritis and ulcerative colitis, and many patients stay on it for years or even decades. There is no built-in time limit or point at which you must stop, as long as the drug is working and you’re tolerating it well.
That said, the reality is more nuanced than “take it forever.” Whether you actually stay on sulfasalazine long-term depends on how well it controls your disease, how your body handles it over time, and whether side effects become a problem. Here’s what the data shows about what long-term use looks like in practice.
Most People Don’t Stay on It for Five Years
While sulfasalazine can be taken long-term, many patients end up switching to something else within the first few years. A study of over 1,100 patients with early rheumatoid arthritis found that only about 42% were still taking sulfasalazine after one year. By three years, that dropped to 28%, and by five years, just 20% remained on it. For comparison, methotrexate kept 46% of patients at the five-year mark.
This doesn’t mean sulfasalazine stops working at a predictable point. The main reason people stop is side effects. A large Norwegian registry found that roughly 40% of sulfasalazine users discontinued within the first year due to adverse events, compared to about 14% for methotrexate. Interestingly, the types of side effects weren’t dramatically different between the drugs. Researchers noted that the higher dropout rate may partly reflect how patients and doctors weigh the side effects against available alternatives. If a newer or better-tolerated option exists, there’s less motivation to push through discomfort.
For people who do tolerate sulfasalazine well in the first year or two, the likelihood of continuing long-term is much higher. The early months are the critical window.
What Long-Term Use Looks Like for Each Condition
In rheumatoid arthritis, sulfasalazine works as a disease-modifying drug, meaning it slows joint damage rather than just relieving pain. Since there is no cure for RA, the goal is to stay on an effective disease-modifying drug for as long as it keeps working. Sulfasalazine has been used this way for decades, and it’s common for rheumatologists to keep patients on it year after year if their disease stays under control.
In ulcerative colitis, the picture is slightly different. Sulfasalazine is used both to treat active flares and to maintain remission afterward. The typical maintenance dose is 2 grams per day, split into doses taken every eight hours or less. Because ulcerative colitis is a lifelong condition with unpredictable flares, staying on a maintenance medication indefinitely is standard practice. Coming off it raises the risk of relapse.
Blood Tests You’ll Need Along the Way
Staying on sulfasalazine long-term requires regular monitoring, though guidelines vary on exactly how long that monitoring should continue. During the first three months, expect blood tests every two to four weeks. These check your blood cell counts, liver function, and kidney function. After that initial period, testing typically shifts to every three months for at least the first year.
Where it gets inconsistent is what happens after year one. American College of Rheumatology guidelines recommend continuing blood tests every three months for the entire time you’re on the drug. British Society of Rheumatology guidelines, on the other hand, say monitoring can stop after the first year. The manufacturer’s label recommends three-monthly testing throughout long-term treatment. In practice, your doctor will likely land somewhere in this range based on your individual risk factors and how stable your results have been.
Rare but Serious Risks Over Time
The most common side effects of sulfasalazine, like nausea, headache, and stomach upset, tend to show up early and are the primary reason people discontinue. But long-term use carries a small risk of more serious problems that blood monitoring is designed to catch.
The biggest concerns are blood-related: the drug can, in rare cases, suppress your bone marrow’s ability to produce blood cells. This includes conditions like agranulocytosis (a dangerous drop in white blood cells) and aplastic anemia. Warning signs include unexplained sore throat, fever, unusual bruising, or pale skin. Liver damage is another rare possibility, ranging from mild elevations in liver enzymes to, in very rare cases, severe hepatitis. Lung inflammation has also been reported, though uncommonly.
These serious reactions are rare enough that millions of people have used sulfasalazine safely for years. But they are the reason ongoing blood work matters, especially if your doctor follows the guidelines recommending indefinite monitoring.
Folic Acid and Fertility Considerations
Sulfasalazine interferes with folic acid absorption, which is relevant if you’re on it for years. Many doctors recommend a daily folic acid supplement to prevent deficiency, which can cause a specific type of anemia where red blood cells become abnormally large. If you’re on long-term sulfasalazine and haven’t discussed folic acid supplementation, it’s worth bringing up.
For men, there’s another consideration: sulfasalazine can reduce sperm count. This effect is reversible. Sperm counts typically recover within two to three months of stopping the medication. If you’re planning to conceive, this is something to discuss with your doctor well in advance, since a temporary switch to a different medication may be needed.
When Stopping or Switching Makes Sense
There’s no rule that says you must eventually stop sulfasalazine. If it controls your condition and your blood work stays clean, continuing indefinitely is a reasonable plan. The decision to stop usually comes down to one of a few scenarios: side effects that reduce your quality of life, blood test results showing early signs of a problem, or the drug simply losing its effectiveness at controlling your disease.
For rheumatoid arthritis patients, loss of effectiveness over time sometimes leads doctors to add a second medication or switch to a different disease-modifying drug entirely. This isn’t unique to sulfasalazine; it’s a common pattern with many RA medications. For ulcerative colitis, a breakthrough flare while on maintenance sulfasalazine may signal the need for a stronger treatment approach.
If you’ve been on sulfasalazine for a year or more without significant problems, you’re past the highest-risk period for side effects. The 20% of RA patients still taking it at five years represent a self-selected group who tolerate it well, and many of them continue well beyond that point.